Business Description
Tikun Olam Cannbit Pharmaceuticals Ltd
ISIN : IL0010843675
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.24 | |||||
Equity-to-Asset | 0.32 | |||||
Debt-to-Equity | 1.27 | |||||
Debt-to-EBITDA | -1.07 | |||||
Interest Coverage | 6.7 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -1.36 | |||||
Beneish M-Score | -5.89 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EPS without NRI Growth Rate | -26.7 | |||||
3-Year FCF Growth Rate | 10.8 | |||||
3-Year Book Growth Rate | -15.4 |
Momentum Rank
Name | Current | Vs Industry | Vs History |
---|
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.6 | |||||
Quick Ratio | 0.48 | |||||
Cash Ratio | 0.16 | |||||
Days Inventory | 79.58 | |||||
Days Sales Outstanding | 65.8 | |||||
Days Payable | 31.57 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -25.5 | |||||
Shareholder Yield % | 6.35 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | -13.92 | |||||
Operating Margin % | 32.61 | |||||
Net Margin % | -117.64 | |||||
FCF Margin % | 9.9 | |||||
ROE % | -130.93 | |||||
ROA % | -69.43 | |||||
ROIC % | 21.26 | |||||
ROC (Joel Greenblatt) % | -162.12 | |||||
ROCE % | -113.73 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 0.67 | |||||
PB Ratio | 2.41 | |||||
Price-to-Free-Cash-Flow | 5.51 | |||||
Price-to-Operating-Cash-Flow | 5.43 | |||||
EV-to-EBIT | -0.95 | |||||
EV-to-EBITDA | -2.84 | |||||
EV-to-Revenue | 1.09 | |||||
EV-to-FCF | 11.04 | |||||
Earnings Yield (Greenblatt) % | -105.26 | |||||
FCF Yield % | 12.67 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with GREY:TKUNF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Tikun Olam Cannbit Pharmaceuticals Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 11.728 | ||
EPS (TTM) ($) | -0.242 | ||
Beta | 0 | ||
Volatility % | 0 | ||
14-Day RSI | 0 | ||
14-Day ATR ($) | 0 | ||
20-Day SMA ($) | 1.5 | ||
12-1 Month Momentum % | 0 | ||
52-Week Range ($) | 1.5 - 1.5 | ||
Shares Outstanding (Mil) | 84.96 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Tikun Olam Cannbit Pharmaceuticals Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Tikun Olam Cannbit Pharmaceuticals Ltd Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Tikun Olam Cannbit Pharmaceuticals Ltd Frequently Asked Questions
What is Tikun Olam Cannbit Pharmaceuticals Ltd(TKUNF)'s stock price today?
When is next earnings date of Tikun Olam Cannbit Pharmaceuticals Ltd(TKUNF)?
Does Tikun Olam Cannbit Pharmaceuticals Ltd(TKUNF) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |